Action 30 | Paediatric HIV

AdobeStock_330370789 - 3.jpg

HIV TREATMENT

2020

Pharmaceutical companies, SRAs, WHO Prequalification Programme (PQ) and NRAs commit to:

Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.

Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.

Paediatric HIV & TB : Rome Action Plan

Action 30

Strengthen and expand collaboration to overcome intellectual property challenges and otherwise facilitate technology transfer and knowledge sharing that can promote faster paediatric formulation development, including on challenges like taste-masking.

Committed by:

Pharmaceutical companies

Sub-Actions & Milestones

Sub-action 30.1

Strengthen and expand collaboration to overcome intellectual property challenges

Pharmaceutical company

ViiV is in close discussion with partners in this area and a joint announcement is imminent.

-

Document (s)

-

-

-

-

Sub-action 30.2

Facilitate technology transfer and knowledge sharing to promote faster paediatric formulation development

Pharmaceutical company

-

-

Document (s)

-

-

-

-

Sub-action 30.3

Facilitate technology transfer and knowledge sharing to address taste-masking issues.

Pharmaceutical company

-

-

Document (s)

-

-

-

-

Updates

Notes

Responsible